Fundraising Fox

Petra Kaufmann

Executive at Affinia Therapeutics · Chief Medical Officer at Ovidrx

Bethesda, Maryland, United States

Find your path to Petra

234 people in our graph share verified history with Petra — schools, employers, funds. One of them is your warm intro.

Lisa PurcellunlockedPetra: together at Columbia University Irving Medical Center (2007–2008)
×4Petra: together at The National Institutes of Health
×5Petra: together at Columbia University Irving Medical Center
×2Petra: together at The University of Bonn

Executive at Affinia Therapeutics

Intro paths

→

In turn, Petra can intro founders to Affinia Therapeutics's investors below.

Affinia Therapeutics's investors · 8

Atlas VentureCambridge · $500K – $1M checks · since 2025EcoR1 CapitalSan FranciscoEight Roads VenturesMumbai · $5M – $30M checksF-Prime CapitalCambridge · $3M – $10M checks · since 2025GV (Google Ventures)Mountain View · $250K – $50M checksNEA SecondaryTimonium · since 2025New Enterprise Associates (NEA)Menlo Park · $200K – $40M checksTCG CrossoverPalo Alto

Co-founders at Affinia Therapeutics

LV
Luc VandenbergheDirector
ATAaron Tward, M.D., Ph.D.
Aaron Tward, M.D., Ph.D.Scientific Co-Founder
BRBotond Roska, M.D., Ph.D.
Botond Roska, M.D., Ph.D.Scientific Co-Founder
LV
Luk Vandenberghe, Ph.D.Scientific Co-Founder and Adviser, and Board Member

Chief Medical Officer at Ovidrx

Intro paths

→

In turn, Petra can intro founders to Ovidrx's investors below.

Ovidrx's investors · 2

BioBritLa JollaSanofi VenturesCambridge · $5M checks

Co-founders at Ovidrx

MJMatthew J. During
Matthew J. DuringExecutive Officer, Director
JMJeremy M. Levin
Jeremy M. LevinCo-founder and Executive Chairman

Experience

  1. Ovid TherapeuticsChief Medical Officercurrent2025 — presentNew York, NY
  2. Vigil NeuroscienceChief Medical Officer2024 — 2025Cambridge, Massachusetts, United States
  3. Affinia TherapeuticsChief Medical Officer2021 — 2024
  4. Novartis Gene TherapiesSenior Vice President, Clinical Development, Analytics & Translational Medicine2020 — 2021Bethesda, Maryland, United States
  5. AveXis, Inc.Vice President, R&D Translational Medicine2018 — 2020
  6. The National Institutes of Health/National Center for Advancing Translational SciencesDirector, Office of Rare Diseases Research2015 — 2018
  7. The National Institutes of HealthDirector, Division of Clinical Innovation2014 — 2017
  8. National Institute of Neurological Disorders and Stroke (NINDS)Director, Office of Clinical Research2009 — 2014
  9. Columbia University Irving Medical CenterNeurology Faculty (with tenure)2000 — 2009

Skills & more

ManagementLeadershipStrategic PlanningResearch AdministrationNeurology

Languages English · French · German

  • Preparing to be a Corporate Director — Harvard Business School Executive Education

From Petra's professional profile.

Frequently asked questions

Who is Petra Kaufmann?
Executive Officer at Affinia Therapeutics
Where does Petra Kaufmann work?
Petra Kaufmann is Executive at Affinia Therapeutics and Chief Medical Officer at Ovidrx.
Where did Petra Kaufmann go to school?
Petra Kaufmann studied at Columbia University (Master of Science, Biostatistics/Patient-oriented Research); Columbia University (Neurology Residency Program); Columbia University (Post-doctoral Fellowship, Mitochondrial diseases, molecular genetics).

Same school

Also attended Columbia University1,302

Ben HorowitzCo-founder & General Partner at Andreessen HorowitzDoug LeonePartner at Sequoia Capital; former Global Managing PartnerChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzKai-Fu LeeChairman of Sinovation Ventures and CEO of 01.AIGabriella GiglioHR & Executive Talent at General CatalystScott BillerInvestor at GV (Google Ventures)

+ 1,296 more

Also attended The University of Bonn60

Miriam UeberallTuring Labs AI; Ex-R&D at Flora Food Group, Kraft Heinz, Unilever at PeakBridge VCJörg BinnenbrückerManaging Partner at CapnamicStella PaffenholzSenior Associate at Atlas VentureLennart SchlegelManager Investor Relations at FoodLabsChristophe WagnerInterim CFO at FoodLabsPetra KurschatTeam Manager at Seed+Speed

+ 54 more

Shared employers

Also worked at Ovid Therapeutics7

Meg AlexanderPresident & Chief Executive Officer at OvidrxCharles CarterChief Financial Officer at OvidrxVictoria FortChief Strategy Officer at OvidrxManal MorsyChief Regulatory Officer at OvidrxKevin NorrettChief Business Officer at OvidrxJason TardioPresident and Chief Operating Officer at Imux

+ 1 more

Also worked at Novartis Gene Therapies330

Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures

+ 324 more

Also worked at AveXis, Inc.3

Sean P. NolanChief Executive Officer and Board Chairman at Taysha Gene TherapiesJoseph NolanFounder at Jaguar Gene TherapyDavis RymanExecutive Officer at Aeovian Pharmaceuticals

Also worked at The National Institutes of Health/National Center for Advancing Translational Sciences125

Jun JeonInvestor at Khosla VenturesUri LopatinInvestor at Khosla VenturesMax ColbertPhysician-Entrepreneur at Medical Excellence CapitalLeela SrinivasanCEO, Parity at Bull City Venture PartnersVictoria GraceFounding partner of Colle Capital Partners, an opportunistic early-stage technology venture fundAshok SrinivasanChief Science Advisor at AIF

+ 119 more